LEADER 01074nam0-2200337---450-
001 990004476790403321
005 20111111141831.0
035   $a000447679
035   $aFED01000447679
035   $a(Aleph)000447679FED01
035   $a000447679
100   $a19990604d1927----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $ay-------001yy
200 1 $aPoeti e scrittori d'Italia$fBenedetto Croce$ga cura di F. Del Secolo e G. Castellano
210   $aBari$cGius. Laterza e Figli$d1927
215   $a2 v.$d19 cm
225 1 $aPiccola biblioteca filosofica Laterza
327 1 $a1.: Da Dante a V. Cuoco$a2.: Da Alfieri a Pascoli
700  1$aCroce,$bBenedetto$f<1866-1952>$09641
702  1$aCastellano,$bGiovanni$f<1878-1951>
702  1$aDel Secolo,$bFloriano
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990004476790403321
952   $aP.1 9I CROCE 112 (1)$bBibl. 19736$fFLFBC
952   $aP.1 9I CROCE 112 (2)$bBibl. 19736$fFLFBC
959   $aFLFBC
996   $aPoeti e scrittori d'Italia$9546114
997   $aUNINA

LEADER 03098nam  2200649 a 450 
001 9910457137103321
005 20200520144314.0
010   $a1-283-01910-8
010   $a9786613019103
010   $a0-309-15890-7
035   $a(CKB)2550000000032026
035   $a(EBL)3378748
035   $a(SSID)ssj0000507437
035   $a(PQKBManifestationID)11344055
035   $a(PQKBTitleCode)TC0000507437
035   $a(PQKBWorkID)10562131
035   $a(PQKB)10436788
035   $a(MiAaPQ)EBC3378748
035   $a(Au-PeEL)EBL3378748
035   $a(CaPaEBR)ebr10454969
035   $a(CaONFJC)MIL301910
035   $a(OCoLC)923283190
035   $a(EXLCZ)992550000000032026
100   $a20110414d2011      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aBuilding a national framework for the establishment of regulatory science for drug development$b[electronic resource] $eworkshop summary /$fInstitute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
210   $aWashington, D.C. $cNational Academies Press$d2011
215   $a1 online resource (95 p.)
300   $a"Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy."
311   $a0-309-15889-3 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies""
606   $aPharmaceutical policy$zUnited States$vCongresses
606   $aDrug development$xGovernment policy$zUnited States$vCongresses
606   $aPharmaceutical industry$xGovernment policy$zUnited States$vCongresses
608   $aElectronic books.
615  0$aPharmaceutical policy
615  0$aDrug development$xGovernment policy
615  0$aPharmaceutical industry$xGovernment policy
676   $a615.1
701   $aLebovitz$b Yeonwoo$0936149
701   $aEnglish$b Rebecca A$0897032
701   $aClaiborne$b Anne B$0897033
712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
712 12$aBuilding a National Framework for the Establishment of Regulatory Science for Drug Development$f(2010 :$eWashington, D.C.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910457137103321
996   $aBuilding a national framework for the establishment of regulatory science for drug development$92125496
997   $aUNINA